Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/30/2003US20030203871 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203861 Nucleic acid vector containing a non-coding, immunostimulatory polynucleotide, comprised of six nucleotides arranged in the sequence 5'-purine-purine-unmethylated CpG-pyrimidine-pyrimidine-3'
10/30/2003US20030203860 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
10/30/2003US20030203859 A combination of a bis-aryl compound (such as fipronil) and an avermectin or milbemycin or derivative useful as parasitic agent
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203854 Composition for effecting serum cholesterol levels
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
10/30/2003US20030203846 Administering to a cancer patient at least one treatment modality, containing a tyrosine kinase inhibitor and a purified heat shock protein to cure the cancer
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203836 Methods for reduced renal uptake of protein conjugates
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203482 Stimulation of cellular regeneration and differentiation tn the inner ear
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203097 Acidic compositions comprising protein and fiber and processes of their preparation
10/30/2003US20030203057 A mixture of isoflavones or isoflavone glycosides, pungent, bitter and sour substances and/or scymnol and scymnol esters; secretion of biogenic monoamines; antidepressants; seasonal affective disorder; Alzheimer's disease and much more!
10/30/2003US20030203055 Administering a selective norepinephrine norepinephrine-serotonin reuptake inhibitor, e.g., milnacipran, that is not a tricylcic antidepressant; gastrointestinal and urogenital disorders; analgesics
10/30/2003US20030203053 Method and composition for improving sexual fitness
10/30/2003US20030203051 Plant extracts for the treatment of increased bone resorption
10/30/2003US20030203049 Triterpene compositions and methods for use thereof
10/30/2003US20030203048 Oral administration to counteract dehydration resulting from vomiting, diarrhea, physical exercise or illness; especially suitable for infants, small children and the elderly; water, sodium, potassium, citrate, carbonate and structuring
10/30/2003US20030203047 Composition and method for increasing testosterone levels
10/30/2003US20030203046 Solutions and aerosols of metal-containing compounds
10/30/2003US20030203045 Therapeutic composition for the treatment of HIV-1 and HIV-2
10/30/2003US20030203043 Composition and method for increasing testosterone levels
10/30/2003US20030203042 Food, beverage
10/30/2003US20030203038 Targeted delivery of bioactive factors to the systemic skeleton
10/30/2003US20030203037 Dosage forms which can be administered parenterally and comprise a suspension of the salt of tramadol and diclofenac
10/30/2003US20030203036 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
10/30/2003US20030203034 Compositions for treating hyperemia
10/30/2003US20030203033 Biodegradation organophosphorus polymer; administering to tumor in situ
10/30/2003US20030203031 Immune modulation with polystyrene sulfonate
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030203026 Compressed tablet containing non-steroid antiinflammatory drug
10/30/2003US20030203025 Sustained release oral formulations
10/30/2003US20030203021 Pharmaceutical compositions containing epinastine and pseudoephedrine
10/30/2003US20030203020 Pharmaceutical compositions for piperidinoalkanol compounds
10/30/2003US20030203019 Coated conditioners for use in foods and pharmaceuticals
10/30/2003US20030203018 Stable oral pharmaceutical dosage forms
10/30/2003US20030203017 Plaster for topical use containing heparin and diclofenac
10/30/2003US20030203006 Immunomodulator
10/30/2003US20030203005 Mixing lipid and proteins; applying shear
10/30/2003US20030203004 Dietetics; controlling appetite
10/30/2003US20030203003 Drug releasing biodegradable fiber implant
10/30/2003US20030202997 Killing parasites with fatty ester and organosilicon compound
10/30/2003US20030202994 Excitatory amino acid inhibitors for treating sensitive skins
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202970 Carboxymethylcellulose sponges, membranes, gels, particles; anticoagualnts, drug delivery
10/30/2003US20030202969 Enhancing therapeutic effectiveness of nitric oxide inhalation
10/30/2003US20030202961 Methods of therapy for HIV infection
10/30/2003US20030202959 Polymeric acyl derivatives of indoles
10/30/2003US20030202958 Dialysis solution including polyglycol osmotic agent
10/30/2003US20030202957 Aqueous mixture of salt and polyoxyethylene glycol; laxative
10/30/2003US20030202951 Method for reducing the appearance of dark circles under the eyes
10/30/2003US20030202946 Bactericides
10/30/2003US20030202935 Using folinic acid; analgesics, muscle relaxants, antiinflammatory agents, psychological disorders
10/30/2003US20030201160 Sterilization, neutralization of infectous viruses in blood; removal adenine, exposure to photosentizer
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2770411A1 Aerosol containing a particulate active substance
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003CA2636960A1 Pharmaceutical composition comprising a specific inhibitor of hedgehog/smoothened signaling and a corticosteroid
10/30/2003CA2484384A1 Preventives for hiv infection
10/30/2003CA2484017A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003CA2483474A1 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2483311A1 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003CA2483227A1 Antiviral inhibition of capsid proteins
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482928A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482717A1 Polymorph of ascomycin derivative
10/30/2003CA2482715A1 Antiviral lactone-ureas
10/30/2003CA2482714A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003CA2482712A1 Compounds useful in preparing camptothecin derivatives
10/30/2003CA2482705A1 Use of meglumine for inhibiting 3-deoxyglucosone synthesis in the skin
10/30/2003CA2482593A1 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/30/2003CA2482591A1 Combination therapy for the treatment of cancer
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003CA2482508A1 Combination therapy for the treatment of cancer
10/30/2003CA2482464A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003CA2482445A1 Amonafide salts
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482249A1 Dry powder inhalant composition
10/30/2003CA2482147A1 Medicament for therapeutic treatment of vascular disease
10/30/2003CA2482037A1 Condom
10/30/2003CA2482035A1 Novel sodium channel blockers
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003CA2481934A1 Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
10/30/2003CA2481753A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003CA2481749A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/30/2003CA2481524A1 Method of inhibiting restenosis
1 ... 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 ... 7860